Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket
Lilly hiked its full-year sales outlook by $2 billion, and also raised its adjusted profit guidance.
原文: https://www.cnbc.com/2026/04/30/eli-lilly-lly-earnings-q1-2026.html
Last Update:
30 4 月, 2026